Beijing, March 2 (IANS) China conditionally approved the registration application of a self-developed recombinant protein subunit vaccine against Covid-19, the National Medical Products Administration said Wednesday.The vaccine, developed by Anhui Zhifei Longcom Biopharmaceutical Co, Ltd., was allowed to enter the market on a conditional basis, said the administration, Xinhua news agency reported.It marked the first approved Covid recombinant protein subunit vaccine in China.
--IANS int/sks
(Disclaimer: This post has been auto published from IANS news agency without any modification to the text and has not been reviewed by editor)
